Identification

Generic Name
4-hydroxyphenacyl coenzyme A
DrugBank Accession Number
DB03613
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 901.666
Monoisotopic: 901.151987801
Chemical Formula
C29H42N7O18P3S
Synonyms
Not Available

Pharmacology

Indication

Not Available

再保险duce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Target Actions Organism
U4-hydroxybenzoyl-CoA thioesterase Not Available Arthrobacter sp.
U4-hydroxybenzoyl-CoA thioesterase Not Available Pseudomonas sp. (strain CBS-3)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided byClassyfire
Description
This compound belongs to the class of organic compounds known as s-alkyl-coas. These are alkyl sulfides consisting of coenzyme A that carries an S-alkyl substituent.
Kingdom
Organic compounds
Super Class
Lipids and lipid-like molecules
Class
S-alkyl-CoAs
Sub Class
Not Available
Direct Parent
S-alkyl-CoAs
Alternative Parents
Coenzyme A and derivatives/Purine ribonucleoside diphosphates/Pentose phosphates/Ribonucleoside 3'-phosphates/Alkyl-phenylketones/Beta amino acids and derivatives/Glycosylamines/Organic pyrophosphates/Monosaccharide phosphates/6-aminopurines
show 20 more
Substituents
1-hydroxy-2-unsubstituted benzenoid/6-aminopurine/Alcohol/Alkyl phosphate/Alkyl-phenylketone/Amine/Amino acid or derivatives/Aminopyrimidine/Aromatic heteropolycyclic compound/芳基烷基刃one
show 56 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
ZQLMPRRTUJBILA-VXAHOBLNSA-N
InChI
InChI=1S/C29H42N7O18P3S/c1-29(2,24(41)27(42)32-8-7-20(39)31-9-10-58-12-18(38)16-3-5-17(37)6-4-16)13-51-57(48,49)54-56(46,47)50-11-19-23(53-55(43,44)45)22(40)28(52-19)36-15-35-21-25(30)33-14-34-26(21)36/h3-6,14-15,19,22-24,28,37,40-41H,7-13H2,1-2H3,(H,31,39)(H,32,42)(H,46,47)(H,48,49)(H2,30,33,34)(H2,43,44,45)/t19-,22-,23-,24+,28-/m1/s1
IUPAC Name
{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-({2-[(2-{[2-(4-hydroxyphenyl)-2-oxoethyl]sulfanyl}ethyl)carbamoyl]ethyl}carbamoyl)-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid
SMILES
[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSCC(=O)C4=CC=C(O)C=C4)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1

再保险ferences

一般References
Not Available
PubChem Compound
446968
PubChem Substance
46506287
ChemSpider
394187
ZINC
ZINC000195757457
PDBe Ligand
4CO
PDB Entries
1lo7/1q4t/3r32/3r35/3r37/3r3b/3r3c/3r3d/3r3f/3tea

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Property Value Source
Water Solubility 3.26 mg/mL ALOGPS
logP -0.06 ALOGPS
logP -4.9 Chemaxon
logS -2.4 ALOGPS
pKa (Strongest Acidic) 0.83 Chemaxon
pKa (Strongest Basic) 4.89 Chemaxon
Physiological Charge -4 Chemaxon
Hydrogen Acceptor Count 18 Chemaxon
Hydrogen Donor Count 10 Chemaxon
Polar Surface Area 383.862 Chemaxon
Rotatable Bond Count 22 Chemaxon
再保险fractivity 199.42 m3·mol-1 Chemaxon
Polarizability 81.07 Å3 Chemaxon
Number of Rings 4 Chemaxon
Bioavailability 0 Chemaxon
Rule of Five No Chemaxon
Ghose Filter No Chemaxon
Veber's Rule No Chemaxon
MDDR-like Rule Yes Chemaxon
Predicted ADMET Features
Property Value Probability
Human Intestinal Absorption + 0.8738
Blood Brain Barrier - 0.8453
Caco-2 permeable - 0.7061
P-glycoprotein substrate Substrate 0.8586
P-glycoprotein inhibitor I Non-inhibitor 0.6332
P-glycoprotein inhibitor II Non-inhibitor 0.9858
再保险nal organic cation transporter Non-inhibitor 0.937
CYP450 2C9 substrate Non-substrate 0.7937
CYP450 2D6 substrate Non-substrate 0.7776
CYP450 3A4 substrate Substrate 0.6479
CYP450 1A2 substrate Non-inhibitor 0.8251
CYP450 2C9 inhibitor Non-inhibitor 0.8131
CYP450 2D6 inhibitor Non-inhibitor 0.8095
CYP450 2C19 inhibitor Non-inhibitor 0.8189
CYP450 3A4 inhibitor Non-inhibitor 0.6077
CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8824
Ames test Non AMES toxic 0.6723
Carcinogenicity Non-carcinogens 0.7948
Biodegradation Not ready biodegradable 1.0
Rat acute toxicity 2.5810 LD50, mol/kg Not applicable
hERG inhibition (predictor I) Weak inhibitor 0.874
hERG inhibition (predictor II) Inhibitor 0.6128
ADMET data is predicted usingadmetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
Spectrum Spectrum Type Splash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets tounlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Arthrobacter sp.
Pharmacological action
Unknown
General Function
4-hydroxybenzoyl-coa thioesterase activity
Specific Function
Not Available
Gene Name
fcbC
Uniprot ID
Q04416
Uniprot Name
4-hydroxybenzoyl-CoA thioesterase
分子量
16394.32 Da
Kind
Protein
Organism
Pseudomonas sp. (strain CBS-3)
Pharmacological action
Unknown
General Function
4-hydroxybenzoyl-coa thioesterase activity
Specific Function
Hydrolyzes 4-hydroxybenzoate-CoA, and to a lesser extent benzoyl-CoA and 4-chlorobenzoate-CoA. Not active against aliphatic acyl-CoA thioesters, including palmitoyl-CoA, hexanoyl-CoA and acetyl-CoA.
Gene Name
Not Available
Uniprot ID
P56653
Uniprot Name
4-hydroxybenzoyl-CoA thioesterase
分子量
16105.3 Da

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52